A long-term efficacy study of gene replacement therapy for RPGR-associated retinal degeneration

Mutations in the retinitis pigmentosa GTPase regulator (RPGR) gene account for >70% of X-linked retinitis pigmentosa (XLRP) and 15–20% of all inherited retinal degeneration. Gene replacement therapy for RPGR-XLRP was hampered by the relatively slow disease progression in mouse models and by diffi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Hum Mol Genet
Hlavní autoři: Wu, Zhijian, Hiriyanna, Suja, Qian, Haohua, Mookherjee, Suddhasil, Campos, Maria M., Gao, Chun, Fariss, Robert, Sieving, Paul A., Li, Tiansen, Colosi, Peter, Swaroop, Anand
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2015
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4476444/
https://ncbi.nlm.nih.gov/pubmed/25877300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/hmg/ddv134
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky